Find Experts

Experts in Haematology
Julio A Aguirre-Ghiso Alberto Toso Yan Xiaojing William G. Finn Afua Mensah Scott A. Armstrong Richard Oscar Francis Jose Javier Bravo Cordero Steven J Burakoff Arek Z. Dudek Balkrishna Jahagirdar Dan J. Schneider Dr. David Saunders Bamlaku Enawgaw Dylan Zylla Muhammad Yasin Tipu Mr. Máté SZILASSY Mr. Roberto MARCOS Mr. Brian CONIBERE Mr. Julio FREYRE View More
Vivian Oehler

Associate Professor
Hematology
Fred Hutchinson Cancer Rearch Center
United States of America

Professor Haematology
Biography

Dr. Oehler graduated from the Case Western Reserve University School of Medicine in 1997. She works in Seattle, WA and specializes in Hematology/Oncology and Internal Medicine . Dr. Oehler is affiliated with Seattle Childrens Hospital and University Of Washington Medical Center. She speaks Chinese ,English , French and Spanish Education M.D., Case Western Reserve University, Medicine, 1997. B.A., Harvard University, Government, 1989.

Research Intrest

Mechanisms of leukemic disease progression and therapy resistance, new agents in the treatment of chronic myeloid leukemia (CML) and acute myeloid leukemia (AML)

List of Publications
Ito H, Kwon HY, Zimdahl B, Congdon KL, Blum J, Lento W, Zhao C, Lagoo A, Gerrard G, Foroni L, Goldman J, Goh H, Kim SH, Kim DW, Chuah C, Oehler VG, Radich J, Jordan CT, and Reya T. Regulation of myeloid leukemia by the cell fate determinant Musashi. Nature. 2010; 466(7307): 765-768. PMID 20639863.
Oehler VG*, Yeung KY*, Choi YE, Bumgarner RE, Raftery AE, et al. The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray data. Blood. 2009; 114(15): 3292-3298. PMID 19654405
Oehler VG, Guthrie K, Cummings CL, Sabo K, Wood BL, et al. Preferentially Expressed Antigen in Melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells. Blood. 2009;114(15): 3299-3308. PMID 19625708.
Oehler VG, Qin J, Ramakrishnan R, Facer G, Ananthnarayan S, et al. Absolute quantitative detection of ABL tyrosine kinase domain point mutations using a novel nanofluidic platform and mutation-specific PCR. Leukemia. 2009; 23(2): 396-399. PMID 18615105.
Oehler VG, Gooley T, Snyder DS, Johnston L, Lin A, et al. The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia. Blood. 2007; 109(4): 1782-1789. PMID 17062727.
Experts in United States of America
Jairaj K. Acharya John Belote Wayde Brown Aimée M. Dudley Jon P Mochel Rabaa M. Al-Rousan Chancellor, Renate Karen Lee Abt Lin Li Hui-Hsien Chou Hamed I. Aly Cory K. Adams Mark Ehrensberger Jose Buitrago Gerhard J. Barone Jacquelyne Adams Jon Calabria Shelley Cannady Susan B. Adams Stoica George Daniel E. Acuna Tal Amasay Jason R. Wiles Matthew H Andersen Brian Rothman View More